首页> 外国专利> Method is used to prepare -7-/(1S) -1 hydroxyl -1,2 of 7,8 dihydros of (6R, 7R, 14S) -17-CYCLOPROPYLMETHYL, 2 TRIMETHYLPROPYL/-6-0- methyl -6,14- ethano- -17- normorphines

Method is used to prepare -7-/(1S) -1 hydroxyl -1,2 of 7,8 dihydros of (6R, 7R, 14S) -17-CYCLOPROPYLMETHYL, 2 TRIMETHYLPROPYL/-6-0- methyl -6,14- ethano- -17- normorphines

机译:该方法用于制备(6R,7R,14S)-17-环丙基甲基,7,3-丙基(2-S)的7,8二氢的-7-/(1S)-1羟基-1,2,-6三甲基丙基/ -6-0-甲基-6,14 -乙醇--17-吗啡

摘要

Method prepares (6R, 7R, 14S) -17-cyclopropylmethyl 7,8-dihydro-7-/(1s) -1-hydroxy-1,2,2-trimethylpropyl/ -6-0-methyl-6, the 14-ethano-17-normorphine of general formula I, as strong anodyne (buprenorphine). Synthesize including while cracking the acylation secondary amide generation of main functional group and hydrolysis cyane group bies alkaline hydrated oxide passes through complex hydride by cyclopropyl carbonyl chloride and subsequent reduction generation amide; possible direct alkylation secondary amide is by Cvclopropvlmethvl halide, and double bond. of final catalysis reduction inner ringIMAGE
机译:方法制备(6R,7R,14S)-17-环丙基甲基7,8-二氢-7-/(1s)-1-羟基-1,2,2-三甲基丙基/ -6-0-甲基-6,14-通式I的ethano-17-normorphine,为强止痛剂(丁丙诺啡)。合成包括在裂解的同时使主要官能团和水解氰基的二酰氨基生成,碱性水合氧化物通过环丙基羰基氯经过络合物氢化物,然后还原生成酰胺。可能的直接烷基化仲酰胺是通过Cvclopropvlmethvl卤化物和双键。最终催化还原内环的组成

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号